PDL BioPharma Inc (NASDAQ:PDLI)

3.37
Delayed Data
As of Apr 24
 -0.11 / -3.16%
Today’s Change
2.25
Today|||52-Week Range
3.89
+16.21%
Year-to-Date

Today’s Trading

Previous close3.48
Today’s open3.48
Day’s range3.36 - 3.48
Volume893,058
Average volume (3 months)1,594,639
Market cap$458.6M
Data as of 4:00pm ET, 04/24/2019

Growth & Valuation

Earnings growth (last year)-166.58%
Earnings growth (this year)+154.26%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-38.10%
P/E ratioNM
Price/Sales2.13
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.55-4.39%
ELOXEloxx Pharmaceutical...-0.46-3.69%
TBIOTranslate Bio Inc-0.35-3.59%
SIGASIGA Technologies In...-0.10-1.85%
Data as of 4:00pm ET, 04/24/2019

Financials

Next reporting dateMay 8, 2019
EPS forecast (this quarter)$0.08
Annual revenue (last year)$198.1M
Annual profit (last year)-$68.9M
Net profit margin-34.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Dominique Monnet
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts